Stewart D, Bodey G P, LeBlanc B
Antimicrob Agents Chemother. 1977 Jun;11(6):1017-20. doi: 10.1128/AAC.11.6.1017.
Netilmicin, a semisynthetic derivative of sisomicin, was tested in vitro against 600 clinical bacterial isolates. At a concentration of 1.56 mug/ml, over 90% of gram-negative bacilli were inhibited. Netilmicin was substantially more active against isolates of Serratia marcescens and Enterobacter spp. than gentamicin, sisomicin, tobramycin, or amikacin. Isolates of Staphylococcus aureus (both penicillin G susceptible and resistant) were quite susceptible to netilmicin. Most isolates of Klebsiella spp. and Serratia spp. and some of the isolates of Pseudomonas aeruginosa that were resistant to gentamicin proved to be susceptible to netilmicin.
奈替米星是西索米星的半合成衍生物,对600株临床分离细菌进行了体外试验。在浓度为1.56微克/毫升时,超过90%的革兰氏阴性杆菌受到抑制。奈替米星对粘质沙雷氏菌和肠杆菌属菌株的活性明显高于庆大霉素、西索米星、妥布霉素或阿米卡星。金黄色葡萄球菌(对青霉素G敏感和耐药的菌株)对奈替米星相当敏感。大多数克雷伯菌属和沙雷氏菌属菌株以及一些对庆大霉素耐药的铜绿假单胞菌菌株对奈替米星敏感。